Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer - Concepedia

Concepedia

Publication | Closed Access

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer

41

Citations

14

References

2024

Year

François Poumeaud, Mathilde Morisseau, Luc Cabel, A. Gonçalves, Catherine Rivier, Olivier Trédan, E. Volant, Jean‐Sébastien Frenel, Sylvain Ladoire, William Jacot,

British Journal of Cancer

Trastuzumab DeruxtecanBreast OncologySacituzumab GovitecanMedicinePharmacologyPathologyAdministration SequenceBreast CancerCancer TreatmentOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1